Analyze Portfolio
NYSE · Consumer Discretionary

iHuman Inc. (IH)

As-reported financials and recent SEC filings for iHuman Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue
$807.0M
Net income
$95.4M
Net margin
11.8%
Diluted EPS
$0.36
ROE
9.6%
P/E (TTM)
Market cap
Debt / equity

Income statement (as reported)

LineFY2025FY2024FY2023FY2022FY2021
Revenue$807.0M$922.2M$1.02B$985.5M$944.7M
Gross profit$547.6M$640.2M$721.3M$691.2M$660.6M
Operating income$66.8M$71.9M$159.9M$111.6M$-54.2M
Net income$95.4M$98.6M$180.9M$109.8M$-37.1M
Diluted EPS$0.36$0.36$0.66$0.41$-0.14

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

6-K2026-06-29
View on EDGAR →
6-K2026-06-01
View on EDGAR →
20-F2026-04-24
View on EDGAR →
6-K2026-03-31
View on EDGAR →

Largest Consumer Discretionary peers

All Consumer Discretionary companies →

Go deeper on IH

Search iHuman Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.